JennaDeyGoldbergMD

Oncology • New York, NY

Hematologic Oncology

Instructor, Medicine, Weill Cornell Medical College

Join to view full profile

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goldberg's full profile

Already have an account?

Office
5141 Broadway
New York, NY 10034
Phone+1 212-932-4439

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Johns Hopkins UniversityResidency, Internal Medicine, 2003 - 2006
Johns Hopkins University School of MedicineClass of 2003

Certifications & Licensure

NY State Medical License 2006 - 2025

Clinical Trials

Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2012 Dec 01
Active, not recruiting
Phase 2
A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma Start of enrollment: 2013 Jul 16
Active, not recruiting
Phase 2
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

682 citations
Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Ying Taur, Joao B. Xavier, Lauren Lipuma, Carles Ubeda, Jenna D. Goldberg
Clinical Infectious Diseases. 2012-10-01
297 citations
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai, Mukta Arora, Tao Wang, Stephen R. Spellman, Wensheng He
Biology of Blood and Marrow Transplantation. 2015-02-01
129 citations
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation
Miguel-Angel Perales, Jenna D. Goldberg, Jianda Yuan, Guenther Koehne, Lauren Lechner
Blood. 2012-12-06

Abstracts/Posters

Translational Analysis from CARTITUDE-1, an Ongoing Phase 1b/2 Study of JNJ-4528 BCMA-targeted CAR-T Cell Therapy in Relapsed and/or Refractory Multiple Myeloma (R/R M...
Jenna D. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refr...
Jenna D. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019